Ivaylo Gentschev

Summary

Country: Germany

Publications

  1. request reprint
    Gentschev I, Dietrich G, Spreng S, Neuhaus B, Maier E, Benz R, et al. Use of the alpha-hemolysin secretion system of Escherichia coli for antigen delivery in the Salmonella typhi Ty21a vaccine strain. Int J Med Microbiol. 2004;294:363-71 pubmed
    ..Therefore, the combination of the hemolysin secretion system and S. typhi Ty21a could form the basis for a new generation of live bacterial vaccines. ..
  2. Adelfinger M, Bessler S, Frentzen A, Cecil A, Langbein Laugwitz J, Gentschev I, et al. Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy. Viruses. 2015;7:4075-92 pubmed publisher
    ..In summary, these findings indicate that GLV-5b451 has potential for use as a therapeutic agent in the treatment of CSTS. ..
  3. Gentschev I, Fensterle J, Schmidt A, Potapenko T, Troppmair J, Goebel W, et al. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice. BMC Cancer. 2005;5:15 pubmed
    ..The combination of the C-Raf antigen, hemolysin secretion system and Salmonella enterica serovar Typhimurium could form the basis for a new generation of live bacterial vaccines for the treatment of Raf dependent human malignancies. ..